The purpose of this study is to evaluate the clinical utility of specific autoantibody
testing in unmasking an underlying connective tissue disorder in patients who present with
interstitial lung disease and found to have weak positive ANA (1:400 titre) with no overt
connective tissue disease manifestations OR borderline/negative ANA with some clinical
suggestion of connective tissue disease.